Del Rosso M, Fibbi G, Dini G, Grappone C, Pucci M, Caldini R, Magnelli L, Fimiani M, Lotti T, Panconesi E
Institute of General Pathology, Florence University, Italy.
J Invest Dermatol. 1990 Mar;94(3):310-6. doi: 10.1111/1523-1747.ep12874442.
On the basis of both 125I-labeled plasminogen activator binding analysis and transmission electron microscopy studies of the interaction of a plasminogen activator/gold complex with cell membranes, we have found that human keratinocytes have specific receptors for human urokinase-type plasminogen activator distributed on the cell surface as singlets, or as small or large clusters. The use in binding experiments of the purified A chain of urokinase-plasminogen activator and of anti-A chain monoclonal antibodies has indicated that cell receptors are specific for a sequence present on the A chain, as previously reported for other cells. The interaction of both the native molecule and the purified A chain with such receptors stimulates mobilization of keratinocytes in an in vitro cell model system (Boyden chamber), when present in the lower compartment of the migration apparatus in nanomolar concentrations. Preincubation of chemoattractants with a monoclonal antibody which prevents receptor/ligand interaction also prevents plasminogen activator-induced cell migration. These data suggest that, under the conditions used in this in vitro model system, the plasminogen activator-dependent mobilization of keratinocytes depends on the interaction of the ligand with free receptors on the cell surface, and is independent of plasmin generation.
基于¹²⁵I标记的纤溶酶原激活物结合分析以及纤溶酶原激活物/金复合物与细胞膜相互作用的透射电子显微镜研究,我们发现人角质形成细胞具有人尿激酶型纤溶酶原激活物的特异性受体,这些受体以单体形式或小簇或大簇形式分布在细胞表面。尿激酶 - 纤溶酶原激活物纯化A链和抗A链单克隆抗体在结合实验中的应用表明,细胞受体对A链上存在的序列具有特异性,正如先前在其他细胞中所报道的那样。当天然分子和纯化的A链以纳摩尔浓度存在于迁移装置的下室时,它们与这些受体的相互作用会在体外细胞模型系统(Boyden小室)中刺激角质形成细胞的迁移。趋化剂与防止受体/配体相互作用的单克隆抗体预孵育也会阻止纤溶酶原激活物诱导的细胞迁移。这些数据表明,在该体外模型系统所使用的条件下,纤溶酶原激活物依赖性角质形成细胞的迁移取决于配体与细胞表面游离受体的相互作用,并且与纤溶酶的产生无关。